Screener
Ingevity NGVT SG&A
SG&A at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Ingevity in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The source filing: Ingevity’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:26 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001653477-26-000035
| In millions, except per share data | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Net sales | $258.0 | $247.9 |
| Cost of sales | 141.6 | 136.0 |
| Gross profit | 116.4 | 111.9 |
| Selling, general, and administrative expenses | 40.7 | 41.9 |
| Research and technical expenses | 6.7 | 7.0 |
| Restructuring and other (income) charges, net | 0.5 | 1.9 |
| Other (income) expense, net | 22.4 | 4.1 |
| Interest expense, net | 15.9 | 19.4 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Ingevity's SG&A?
- Ingevity (NGVT) reported SG&A of $40.7M in Q1 2026.
- How has Ingevity's SG&A changed year-over-year?
- Ingevity's SG&A decreased by 2.9% year-over-year, from $41.9M to $40.7M.
- What is the long-term trend for Ingevity's SG&A?
- Over 4 years (2021 to 2025), Ingevity's SG&A has grown at a -1.1% compound annual growth rate (CAGR), from $179.3M to $171.8M.
- What does SG&A mean?
- Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.
Ask your AI about Ingevity's sg&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude